Cero Therapeutics removed from Nasdaq for failing continued-listing standards
Nasdaq delisted Cero Therapeutics Holdings, Inc.'s common stock and warrants on July 13, 2026, under Rule 17 CFR 240.12d2-2(b) for failure to meet…
Company
SEC filing news and material events for CERO THERAPEUTICS HOLDINGS, INC., briefed from primary-source filings.
1 story
Nasdaq delisted Cero Therapeutics Holdings, Inc.'s common stock and warrants on July 13, 2026, under Rule 17 CFR 240.12d2-2(b) for failure to meet…